Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
JACC: CardioOncology is Scopus-indexed (Q1, CiteScore 16.3), WoS SCIE, DOAJ. It is covered by India's One Nation One Subscription scheme, which pays the article processing charge for authors at eligible institutions. Published by Elsevier Inc..
Checked against the index lists dated .
ISSN 2666-0873Verify ISSN ↗
Publisher: Elsevier Inc.
Cost to publish: APC covered for authors at ONOS-subscribed Indian institutions
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Cardiology and Cardiovascular Medicine | 13 / 409 | 96th | Q1 |
| Oncology | 28 / 428 | 93rd | Q1 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription)
Yes — actively indexed in Scopus, coverage 2019–present, best quartile Q1, CiteScore 16.3.
JACC: CardioOncology is Q1 in Cardiology and Cardiovascular Medicine (rank 13 of 409) and Q1 in Oncology (rank 28 of 428), by CiteScore 2025.
JACC: CardioOncology is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 16.3, which places it in quartile Q1 at the 96th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 3.836, quartile Q1, with an H-index of 56.
For authors at Indian institutions covered by One Nation One Subscription (ONOS), the article processing charge is paid by the scheme. The publisher lists an article processing charge of about US$4,200 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
JACC: CardioOncology is published by Elsevier Inc. Its ISSN is 2666-0873.
Yes. ONOS also covers its article processing charge for authors at eligible institutions.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
JACC: CardioOncology has an h-index of 63 and a 2-year mean of 6.94 citations per paper (OpenAlex). Its Scopus CiteScore is 16.3, quartile Q1. On 2-year citations it ranks #9 of 398 Scopus journals in Cardiology and Cardiovascular Medicine.
JACC: CardioOncology published 133 papers in 2025; its busiest recent year was 2022 with 154. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 81 research articles (2025–2026), authors are most often from United States (49.7%), China (6.2%) and Canada (6%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.